Tag: disease
Bill Gates details how his foundation shifted focus “almost entirely” to addressing COVID-19
Microsoft founder Bill Gates spoke to the Financial Times (via Fast Company) about how the work of the Bill & Melinda Gates Foundation has shifted “almost entirely” to working on addressing COVID-19, in the interest of making the post impact possible in the ongoing effort to contain and combat the…
Read More
Curative received FDA emergency use authorization for its novel COVID-19 tests
The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests have already been used by the City of Los Angeles since late March and have tested over 53,000 city residents.…
Read More
Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials
BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as a potential treatment for COVID-19, after it applied its AI platform and team to the problem. The revelation, which has now appeared in peer-reviewed scientific…
Read More
COVID-19 symptom self-reporting app from startup Zoe and academic partners expands to the U.S.
If you want to contribute to efforts to better understand and contain the COVID-19 pandemic, and you’re based in the U.S., you can do a lot with very little effort by downloading a free iOS and Google Play application called simply ‘COVID Symptom Tracker.’ The app was originally developed in…
Read More
Henry Ford Health System to conduct first large U.S. study of hydroxychloroquine’s ability to prevent COVID-19
Despite false assertions by the President to the contrary, any potential treatments to counter or prevent COVID-19 are still only at the stage of early investigations, which include one-off treatment with special individual case authorizations, and small-scale clinical examinations. Nothing so far has approached the level of scrutiny needed to…
Read More
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19. The company, which has raised at least $290 million to date (according to Crunchbase), uses “Natural Killer”…
Read More